Audited Supplier
Yohimbe Bark Extract
RoHS, BRC, ISO, FDA, HACCP
HPLC-MS, GPC, HPLC, UV
Injection, Lotion, Suppository, Paste, Tablet, Capsule
Food, Health Care Products, Medicine
Powder
Yohimbine
Yohimbe Bark Extract
Pausinystalia Yohimbe
Bark
8%-98%
C21h27cln2o
390.904
146-48-5
White or Yellow Powder
295º
Nmt 1%
Nmt 1%
Nmt 2%
Nmt 3000ppm
Nmt 1000 Cfu/G
Nmt 100 Cfu/G
Source herb
Drum
25KG/Drum
China
2106909090
Product Description
Yohimbe Bark Extract
Certificate of Analysis:
| Product Name: | Yohimbe Bark Extract | Latin Name: | Corynante Yohimbe |
| Part used: | Bark | Extract Solvent: | Ethanol & Water |
| Test quantity: | 1000kg | Batch Number: | SH20230330 |
| Production date | 30, MAR, 2023 | Testing date | 30, MAR, 2023 |
| Country of origin | China |
| ITEM | SPECIFICATION | RESULT | TEST METHOD |
| Appearance | Brown Fine Powder | Complies | Visual |
| Odor & Taste | Characteristic | Complies | Organoleptic |
| Sieve Analysis | 100% pass 80 mesh | Complies | 80 Mesh Screen |
| Assay | Yohimbine >8% | 8.1% | HPLC |
| Density | 0.5-0.7g/ml | Complies | |
| Loss on Drying | 5% Max | 3.34% | 5G/105ºC/5hrs |
| Sulphated Ash | 5% Max | 3.16% | 5G/525ºC/3hrs |
| Pesticides | <1ppm | Complies | Gas Chromatography |
| Heavy Metals | 10ppm Max | Complies | Atomic Absorption |
| Arsenic (As) | NMT 2ppm | Complies | Atomic Absorption |
| Cadmium(Cd) | NMT 1ppm | Complies | Atomic Absorption |
| Lead (Pb) | NMT 3ppm | Complies | Atomic Absorption |
| Mercury (Hg) | NMT 0.1ppm | Complies | Atomic Absorption |
| Total Plate Count | 1000cfu/g Max | Complies | CP2010 |
| Yeast & Mold | 100cfu/g Max | Complies | CP2010 |
| Salmonella | Negative | Negative | CP2010 |
| E.Coli | Negative | Negative | CP2010 |
| Aflatoxins B1 | <2ug/kg | Negative | HPLC |
| Aflatoxins (B1,B2,G1,G2) | <4ug/kg | Negative | HPLC |
| Packing | 25kg/drum, Packing in paper-drums and two plastic-bags inside. | ||
| Storage | Store in a well-closed container away from moisture. | ||
| Shelf Life | 2 years if sealed and store away from direct sun light. | ||
| Expiration Date | 2025- MAR .-29 | ||
Product Introduction:
Yohimbine, an indole alkaloid with the molecular formula C21H26N2O.
Product Advantage:
The pharmacological effects of yohimbine mainly include selective blockade of serotonin receptors and ad-renaline receptors, which are related to the central mechanism of erectile function. By selectively blocking presynaptic receptors in ganglia, yohimbine excites brain cells, The free methoxy group in the blood is transylphenylethylene glycol (which increases the force, expands the vascular smooth muscle, increases the tension of peripheral parasympathetic nerve, and reduces the tension of sympathetic nerve, thus expanding the yin lotus artery, increasing the blood flow of the yin lotus cavernous sinus to make it fully erect. However, taking excessive yohimbine will bring about inhibitory effects.
Product Function:
Yohimbine is α 1 receptor blockers have a certain effect on the treatment of male erectile dysfunction. Approximately 50% -60% of male patients with sexual dysfunction show significant therapeutic effects after oral administration of yohimbine.
Yohimbine can be taken for a long time. In addition to improving erectile dysfunction, it can also help patients urinate, reduce prostate volume, and have a certain therapeutic effect on difficulty urinating caused by urinary tract obstruction.
Because yohimbine has a local anesthetic effect similar to co-caine, symptoms such as palpitations, insomnia, and dizziness may occasionally occur.
Due to the similarity of yohimbine to ergotoxine and ergot amine, both have α The receptor blocking effect can reverse the antihypertensive effect of ad-renaline, so it is necessary to pay attention to observing changes in patient blood pressure when using this product in clinical practice.
It cannot be taken together with antihypertensive drugs, such as hydrochlorothiazide and amlodipine.
Packaging Method: MOQ:1KG/BAG 25KG/DRUM
Type of shipping: By DHL, FEDEX, By AIR , By SEA
